Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake
- PMID: 32940941
- PMCID: PMC8074531
- DOI: 10.1002/cphy.c190029
Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake
Abstract
The skeletal muscle is the largest organ in the body, by mass. It is also the regulator of glucose homeostasis, responsible for 80% of postprandial glucose uptake from the circulation. Skeletal muscle is essential for metabolism, both for its role in glucose uptake and its importance in exercise and metabolic disease. In this article, we give an overview of the importance of skeletal muscle in metabolism, describing its role in glucose uptake and the diseases that are associated with skeletal muscle metabolic dysregulation. We focus on the role of skeletal muscle in peripheral insulin resistance and the potential for skeletal muscle-targeted therapeutics to combat insulin resistance and diabetes, as well as other metabolic diseases like aging and obesity. In particular, we outline the possibilities and pitfalls of the quest for exercise mimetics, which are intended to target the molecular mechanisms underlying the beneficial effects of exercise on metabolic disease. We also provide a description of the molecular mechanisms that regulate skeletal muscle glucose uptake, including a focus on the SNARE proteins, which are essential regulators of glucose transport into the skeletal muscle. © 2020 American Physiological Society. Compr Physiol 10:785-809, 2020.
Copyright © 2020 American Physiological Society. All rights reserved.
Figures




Similar articles
-
Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.Dan Med J. 2014 Jul;61(7):B4890. Dan Med J. 2014. PMID: 25123125 Review.
-
p38 MAPK in Glucose Metabolism of Skeletal Muscle: Beneficial or Harmful?Int J Mol Sci. 2020 Sep 4;21(18):6480. doi: 10.3390/ijms21186480. Int J Mol Sci. 2020. PMID: 32899870 Free PMC article. Review.
-
Intracellular mechanisms underlying increases in glucose uptake in response to insulin or exercise in skeletal muscle.Acta Physiol Scand. 2001 Mar;171(3):249-57. doi: 10.1046/j.1365-201x.2001.00827.x. Acta Physiol Scand. 2001. PMID: 11412137 Review.
-
Exocytosis Proteins: Typical and Atypical Mechanisms of Action in Skeletal Muscle.Front Endocrinol (Lausanne). 2022 Jun 14;13:915509. doi: 10.3389/fendo.2022.915509. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35774142 Free PMC article. Review.
-
Enhanced skeletal muscle for effective glucose homeostasis.Prog Mol Biol Transl Sci. 2014;121:133-63. doi: 10.1016/B978-0-12-800101-1.00005-3. Prog Mol Biol Transl Sci. 2014. PMID: 24373237 Review.
Cited by
-
The Correlation Between Visceral Fat Area to Skeletal Muscle Mass Ratio and Multiorgan Insulin Resistance in Chinese Population With Obesity.Int J Endocrinol. 2024 Oct 21;2024:1297584. doi: 10.1155/2024/1297584. eCollection 2024. Int J Endocrinol. 2024. PMID: 39474255 Free PMC article.
-
Unlocking the Potential of Obestatin: A Novel Peptide Intervention for Skeletal Muscle Regeneration and Prevention of Atrophy.Mol Biotechnol. 2024 May;66(5):948-959. doi: 10.1007/s12033-023-01011-7. Epub 2024 Jan 10. Mol Biotechnol. 2024. PMID: 38198052 Review.
-
Does a Ketogenic Diet Have a Place Within Diabetes Clinical Practice? Review of Current Evidence and Controversies.Diabetes Ther. 2024 Jan;15(1):77-97. doi: 10.1007/s13300-023-01492-4. Epub 2023 Nov 15. Diabetes Ther. 2024. PMID: 37966583 Free PMC article. Review.
-
Effects of Gossypetin on Glucose Homeostasis in Diet-Induced Pre-Diabetic Rats.Molecules. 2024 Sep 17;29(18):4410. doi: 10.3390/molecules29184410. Molecules. 2024. PMID: 39339405 Free PMC article.
-
Elucidating the effect of drug-induced mitochondrial dysfunction on insulin signaling and glucose handling in skeletal muscle cell line (C2C12) in vitro.PLoS One. 2024 Sep 17;19(9):e0310406. doi: 10.1371/journal.pone.0310406. eCollection 2024. PLoS One. 2024. PMID: 39288128 Free PMC article.
References
-
- Ahirwar AK, Jain A, Goswami B, Bhatnagar MK, Bhatacharjee J. Imbalance between protective (adiponectin) and prothrombotic (Plasminogen Activator Inhibitor-1) adipokines in metabolic syndrome. Diabetes Metab Syndr 8: 152–155, 2014. - PubMed
-
- Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7: 261–269, 1997. - PubMed
-
- Almendro V, Busquets S, Ametller E, Carbo N, Figueras M, Fuster G, Argiles JM, Lopez-Soriano FJ. Effects of interleukin-15 on lipid oxidation: Disposal of an oral [(14)C]-triolein load. Biochim Biophys Acta 1761: 37–42, 2006. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical